Whether a SpaceX investment pays off “rests almost entirely” on the company’s ability to address a “massive” bottleneck, ...

Have an issue with your financial planner or looking for a new one? Email questions or concerns to picks@marketwatch.com.

Along with several other drugmakers, Novartis has bet that lowering Lp(a) will cut the risk of sometimes fatal cardiovascular events.

Shares in Bombardier lost altitude on Tuesday after President Donald Trump threatened to ban the Canadian aircraft ...

The chip maker is reportedly set to further lift prices on its PC chips as costs rise across the supply chain.

Wall Street's "fear gauge" was rising early Tuesday after the Labor Day holiday, with higher oil prices and bond yields a ...

Qualcomm shares have missed out on the chip sector’s big rally this year. The company is now working on various chip projects ...

It looks like OpenAI is turning things around,” and that’s seen as good news for Oracle, which has a lot riding on the ...

Generation Z and young millennials are navigating major shifts in the economy that have made it harder to build wealth the ...

The blue-chip Dow was down 1.2% in early trade Tuesday, putting the index on pace for its worst daily drop since Aug. 20, ...

Abbott Laboratories said it received FDA approval for its TactiFlex Duo Ablation catheter as a treatment for people with abnormal heart rhythms. The healthcare company said Tuesday that the U.S.

A new partnership will make AT&T the first wireless company to leverage technology from the Amazon Leo satellite unit ...